Adult T-Cell Leukemia Overview

Save information for later
Sign Up

Learn About Adult T-Cell Leukemia

View Main Condition: Leukemia

What is the definition of Adult T-Cell Leukemia?
Adult T-cell leukemia/lymphoma (ATL) is is a rare and aggressive T-cell lymphoma that is linked to infection by the human T-cell lymphotropic virus 1 (HTLV-1). The exact mechanism by which HTLV-I infection causes the ATL is unknown. The clinical features of ATL include generalized swelling of the lymph nodes (lymphadenopathy), increased liver and spleen size (hepatosplenomegaly), immunosuppression, high levels of calcium in the blood, lytic bone lesions (spots that appear as 'holes' on a standard bone x-ray), and skin lesions. There are four basic clinical variants of ATL: acute (60% of cases), lymphomatous (20 % of cases), chronic (10% of cases) and smoldering (10% of cases).
What are the alternative names for Adult T-Cell Leukemia?
  • Adult T-cell leukemia/lymphoma
  • ATLL
  • Adult T-cell leukaemia
  • Adult T-cell leukaemia/lymphoma (HTLV-1 positive)
  • Adult T-cell lymphoma
Who are the top Adult T-Cell Leukemia Local Doctors?
Elite in Adult T-Cell Leukemia
Dr. Thomas P. Loughran
Hematology Oncology | Oncology | Hematology
Elite in Adult T-Cell Leukemia
Dr. Thomas P. Loughran
Hematology Oncology | Oncology | Hematology

University Of Virginia Physicians Group

1215 Lee St, 
Charlottesville, VA 
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Thomas Loughran is a Hematologist Oncology specialist and an Oncologist in Charlottesville, Virginia. Dr. Loughran is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. His top areas of expertise are Adult T-Cell Leukemia, Felty Syndrome, Leukemia, and Acute Myeloid Leukemia (AML). Dr. Loughran is currently accepting new patients.

Elite in Adult T-Cell Leukemia
Dr. Tapan M. Kadia
Hematology | Oncology
Elite in Adult T-Cell Leukemia
Dr. Tapan M. Kadia
Hematology | Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
713-592-5433
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tapan Kadia is a Hematologist and an Oncologist in Houston, Texas. Dr. Kadia is rated as an Elite provider by MediFind in the treatment of Adult T-Cell Leukemia. His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

 
 
 
 
Learn about our expert tiers
Learn More
Masao Matsuoka
Elite in Adult T-Cell Leukemia
Masao Matsuoka
Elite in Adult T-Cell Leukemia
Masao Matsuoka
Kumamoto, JP 

Masao Matsuoka practices in Kumamoto, Japan. Mr. Matsuoka is rated as an Elite expert by MediFind in the treatment of Adult T-Cell Leukemia. His top areas of expertise are Adult T-Cell Leukemia, Leukemia, HTLV-1 Associated Myelopathy, Vitrectomy, and Trabeculectomy.

View All Doctors
What are the latest Adult T-Cell Leukemia Clinical Trials?
Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol
Lymphoid Malignancies and Precursors: Tissue Acquisition Protocol
Enrollment Status: Recruiting
Publish Date: December 17, 2025

Background: \- Lab studies help researchers better understand cancer biology. This information may lead to new methods for diagnosing or treating cancer. To develop these studies, researchers want to collect samples from people with cancer or precancer conditions of the lymph system. These conditions include multiple myeloma, different types of lymphoma, and adult leukemia/lymphoma. The samples collected will...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Pilot Trial to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following CAR T-cell Induced Remission in Pediatric Patients With B Lineage Acute Lymphoblastic Leukemia
A Pilot Trial to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-Cell Recovery to Guide Management Following CAR T-cell Induced Remission in Pediatric Patients With B Lineage Acute Lymphoblastic Leukemia
Enrollment Status: Recruiting
Publish Date: December 17, 2025
Intervention Type: Diagnostic test
Study Phase: Not Applicable

Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat people with relapsed B-ALL. For those who achieve remission after CART alone, it may cure up to 50% of people who receive this therapy. However, for people who relapse after CART, it can be hard to achieve remission again. In patients where CART fails, stem cell transplant (HCT) can be used to pre...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center